📰 Access Program News
Page 174 - Access Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Access Program. Real-time updates on events, politics, business and more.
May 30, 2023
Cattlemen build relationships and expand international marketing opportunities for purebred beef cattle genetics to Mexico.
May 27, 2023
MANHATTAN, Kansas — The Kansas Department of Agriculture — together with the U.S. Livestock Genetics Export, Inc. (USLGE) and the Oklahoma Department of Agricul
May 25, 2023
Minister for Women, Children and Poverty Alleviation, Lynda Tabuya says literacy plays a vital role in transforming individuals into socially engaging citizens.
May 25, 2023
Webinar to take place on Monday, June 5, 2023 at 12:30 PM ETNEW YORK, May 25, 2023) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes
May 25, 2023
The Kansas Department of Agriculture partnered with U.S. Livestock Genetics Export, Inc. (USLGE) and the Oklahoma Department of Agriculture, Food and Forestry to host a beef genetics trade mission from Mexico on May 7 - 12.
May 24, 2023
Highlights Cohort 1 of the SECuRE trial has been completed in 6 participants with metastatic castrate-resistant prostate cancer (mCRPC) who received therapy...
May 24, 2023
The provincial government announced almost $20M in funding for 29 air facilities, including nine in north-central B.C.
May 24, 2023
Highlights Cohort 1 of the SECuRE trial has been completed in 6 participants with metastatic castrate-resistant prostate cancer (mCRPC) who received therapy with 67Cu SAR-bisPSMA at the lowest dose level of 4GBq. No dose limiting toxicities (DLTs) have been reported in cohort 1. The Safety Review Committee (SRC) has recommended that the trial continues to cohort 2. Recruitment has opened at clinical sites in the United States (US) at the cohort 2 dose level of 8GBq and patients are currently in ...
May 24, 2023
Highlights SYDNEY, May 24, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity", "the Company"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce the completion of cohort 1 and advancement to cohort 2 in the therapeutic phase of its Phase I/II...
May 21, 2023
$289,300 to be used to upgrade avgas fuel system